Vincenza Carafa
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Lugli A, Terracciano L, Spagnoli G, Carafa V, Tornillo L, Mele V, Muraro M, Hostettler I, Iezzi G, Zlobec I. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 2010; 103:382-90.
Jul 6, 2010Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Jul 6, 2010Br J Cancer 2010; 103:382-90
Lugli Alessandro, Terracciano L, Spagnoli G, Carafa Vincenza, Tornillo Luigi, Mele V, Muraro M G, Hostettler Isabel, Iezzi Giandomenica, Zlobec Inti
NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study
Bolli M, Spagnoli G, Hudolin T, Terracciano L, Carafa V, Sanguedolce F, Feder C, Gueller U, Zajac P, Schultz-Thater E, Tornillo L. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study. Int J Cancer 2005; 115:960-6.
Jul 20, 2005NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study
Jul 20, 2005Int J Cancer 2005; 115:960-6
Bolli Martin, Spagnoli Giulio C, Hudolin Tvrtko, Terracciano Luigi, Carafa Vincenza, Sanguedolce Francesca, Feder Chantal, Gueller Ulrich, Zajac Paul, Schultz-Thater Elke, Tornillo Luigi